This webinar discusses FDA remediation strategies for medical device companies. It will cover how to assess, plan for, respond to, and follow up on FDA actions like 483s or warning letters through case studies and examples. The objectives are to discuss FDA remediation and quality systems. Attendees will learn best practices for preparing for and handling FDA inspections and responses. The webinar is aimed at medical device professionals and provides a recorded session for on-demand viewing along with a live interactive session.
The webinar discusses current regulatory expectation on how a firm identifies deviations, investigate the cause, recommend corrective, preventive actions.
This course provides an overview of internal auditing requirements and
techniques for medical device companies as a method for risk
management and quality improvement.
The course will cover auditing requirements, audit planning, preparation,
knowledge, auditor skills, interviews, documents and records review,
objective evidence, audit report writing and corrective action.
Guide Preview: The importance of using an accredited enterprise image-viewing...Calgary Scientific Inc.
The Healthcare industry is more dynamic than ever before. Innovative technologies have significantly enhanced the way medical practitioners diagnose patients, review images, seek second opinions, communicate results and generally approach the care they give. According to the Government Accountability Office, 75% of all imaging procedures are performed outside of the hospital setting. Because images are now being accessed remotely, it has become crucial to understand if the technology has been accredited. If it has not, diagnosis or treatment decisions using that technology should never be made.
This guide describes how to decipher between an accredited and non-accredited enterprise image-viewing solutions and the risks of not understanding the differences. http://offers.calgaryscientific.com/resolutionmd4-guides
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
The webinar discusses current regulatory expectation on how a firm identifies deviations, investigate the cause, recommend corrective, preventive actions.
This course provides an overview of internal auditing requirements and
techniques for medical device companies as a method for risk
management and quality improvement.
The course will cover auditing requirements, audit planning, preparation,
knowledge, auditor skills, interviews, documents and records review,
objective evidence, audit report writing and corrective action.
Guide Preview: The importance of using an accredited enterprise image-viewing...Calgary Scientific Inc.
The Healthcare industry is more dynamic than ever before. Innovative technologies have significantly enhanced the way medical practitioners diagnose patients, review images, seek second opinions, communicate results and generally approach the care they give. According to the Government Accountability Office, 75% of all imaging procedures are performed outside of the hospital setting. Because images are now being accessed remotely, it has become crucial to understand if the technology has been accredited. If it has not, diagnosis or treatment decisions using that technology should never be made.
This guide describes how to decipher between an accredited and non-accredited enterprise image-viewing solutions and the risks of not understanding the differences. http://offers.calgaryscientific.com/resolutionmd4-guides
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Raland Compliance Partners provides world-class quality and regulatory compliance and remediation capabilities; from product inception through end of life.
FDA Design Controls: What Medical Device Makers Need to KnowGreenlight Guru
FDA Design Control regulations defined in 21 CFR 820.30 have been in place for 20 years now, yet year after year they continue to be one of the top issues cited during inspections.
This does not, and should not, be the case for your medical device company.
Join us for this free, two-part webinar series presented by two of the world's leading experts on the topic to learn how to implement a design control process that will not only ensure compliance but will actually benefit your product development efforts.
(You can view both webinars here: http://www.greenlight.guru/webinar/medical-device-design-controls)
In Part 1, you'll learn about Intended Use, User Needs, Design Inputs, Design Reviews, Design History File (DHF) and Risk Management.
Specifically:
-The importance of getting your intended use right up front
-The difference between a user need and a design input that's verifiable
-What stakeholders need to be involved in the process and why
-When and how many design reviews you should hold
-Why FMEA alone is NOT risk management and how to integrate risk into the design and development process
In Part 2, you'll learn about Design Outputs, Device Master Record (DMR), Design Verification and Validation (V&V), Design Transfer and Regulatory Submissions.
Specifically:
-Why your design outputs need to be more than a drawing and their relationship to your DMR
-How usability and human factors fits into the overall product development
-Making sure you build the correct device and build it correctly with design V&V
-Common mistakes people make during design transfer to production and how to avoid them
-When you can and should make your regulatory submission
Quality Assurance and Regulatory Compliance for Pharmaceutical Product, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belgaum/Belagavi
Corrective actions current expectation of iso 13458 & fda auditorsOnlineCompliance Panel
Webinar will provide an understanding of current expectations of ISO 13485 notified body auditors regarding containment or correction of nonconformity.
This webinar is intended to help you get familiar with the European Union (EU) Directives governing medical devices including in vitro diagnostic and active implantable medical devices.
This webinar is further intended to provide guidance on the regulatory requirements set out in the applicable Directives, which help assure that medical devices are safe and effective for their intended use.
When medical device companies consider Agile development methods, they often run into the key criticism that Agile groups produce little to no documentation, and that Agile stands in contradiction to the lifecycle standards outlined in IEC 62304.
Webinar on how manufacturers implementing good manufacturing practices managed by quality systems can be in the best compliance with parts 210 and 211.
Get trained on practical aspects of FDA process validation, equipment qualification, Data analysis, statistical tools for Process Quality Management, more.
The 3rd Annual Global Pharmaceutical and Medical Meetings SummitWorldCongress
We are excited to announce the launch of the 3rd Annual Global Pharmaceutical and Medical Meetings Summit ™. The boutique-like Summit gathers senior pharmaceutical, biotech, medical device and healthcare meeting executives for empowering ROI-driven conversations about the industry’s biggest opportunities. Those conversations are amplified in a way no other event can be through ongoing networking and shared best practices.
As usual, World Congress commits to a 50/50 or better ratio of Meeting executive and Solution Providers.
Raland Compliance Partners provides world-class quality and regulatory compliance and remediation capabilities; from product inception through end of life.
FDA Design Controls: What Medical Device Makers Need to KnowGreenlight Guru
FDA Design Control regulations defined in 21 CFR 820.30 have been in place for 20 years now, yet year after year they continue to be one of the top issues cited during inspections.
This does not, and should not, be the case for your medical device company.
Join us for this free, two-part webinar series presented by two of the world's leading experts on the topic to learn how to implement a design control process that will not only ensure compliance but will actually benefit your product development efforts.
(You can view both webinars here: http://www.greenlight.guru/webinar/medical-device-design-controls)
In Part 1, you'll learn about Intended Use, User Needs, Design Inputs, Design Reviews, Design History File (DHF) and Risk Management.
Specifically:
-The importance of getting your intended use right up front
-The difference between a user need and a design input that's verifiable
-What stakeholders need to be involved in the process and why
-When and how many design reviews you should hold
-Why FMEA alone is NOT risk management and how to integrate risk into the design and development process
In Part 2, you'll learn about Design Outputs, Device Master Record (DMR), Design Verification and Validation (V&V), Design Transfer and Regulatory Submissions.
Specifically:
-Why your design outputs need to be more than a drawing and their relationship to your DMR
-How usability and human factors fits into the overall product development
-Making sure you build the correct device and build it correctly with design V&V
-Common mistakes people make during design transfer to production and how to avoid them
-When you can and should make your regulatory submission
Quality Assurance and Regulatory Compliance for Pharmaceutical Product, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belgaum/Belagavi
Corrective actions current expectation of iso 13458 & fda auditorsOnlineCompliance Panel
Webinar will provide an understanding of current expectations of ISO 13485 notified body auditors regarding containment or correction of nonconformity.
This webinar is intended to help you get familiar with the European Union (EU) Directives governing medical devices including in vitro diagnostic and active implantable medical devices.
This webinar is further intended to provide guidance on the regulatory requirements set out in the applicable Directives, which help assure that medical devices are safe and effective for their intended use.
When medical device companies consider Agile development methods, they often run into the key criticism that Agile groups produce little to no documentation, and that Agile stands in contradiction to the lifecycle standards outlined in IEC 62304.
Webinar on how manufacturers implementing good manufacturing practices managed by quality systems can be in the best compliance with parts 210 and 211.
Get trained on practical aspects of FDA process validation, equipment qualification, Data analysis, statistical tools for Process Quality Management, more.
The 3rd Annual Global Pharmaceutical and Medical Meetings SummitWorldCongress
We are excited to announce the launch of the 3rd Annual Global Pharmaceutical and Medical Meetings Summit ™. The boutique-like Summit gathers senior pharmaceutical, biotech, medical device and healthcare meeting executives for empowering ROI-driven conversations about the industry’s biggest opportunities. Those conversations are amplified in a way no other event can be through ongoing networking and shared best practices.
As usual, World Congress commits to a 50/50 or better ratio of Meeting executive and Solution Providers.
How to Manage a Product Medical Device Recall Efficiently and EffectivelyAnita Anzo
Scheduled On : Thursday, July 18, 2013 at 1:00 PM EDT
This webinar will provide valuable assistance and guidance to medical device firms that are either going through or preparing to go through a recall and want to understand the strategy and expectations of a recall and FDA's involvement.
Why should you attend:
Understand Verification and Validation, differences and how they work together
Develop a "Working Definition" of V&V, Qualification, and related terms
Discuss recent regulatory expectations
Software Verification & Validation requirements of the FDA and ISO.
The latest FDA Software Guidance & Regulations, including Part 11 -impact on V&V strategies
Device and Manufacturing software requirements for V & V
How to determine & demonstrate an appropriate V & V strategy
How to determine & handle software for different Levels of Concern
What V&V is required for 3rd Party software-custom and Off-the-shelf
Impact of FDA, Mobile APPS, Cyber Security, and software standards such as IEC 62304
What to look for during software vendor audits.
V & V documentation and level of detail required for device submissions.
How to document a "risk-based" rationale, and use it in a resource-constrained environment
Determine key "milestones" and "tasks" in a project as well as discussing audience related projects for discussion points
why FDA at my Facility is, and what do I do During an InspectionGlobalCompliancePanel
Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer.
Why Design Validation is More Than Testing: How do we Validate our Validation?Greenlight Guru
Validation usually involves a lot of testing. But what tests do we do? What tests do we not do? When can we use standard tests and when do we have to develop new ones? More importantly, how do we know we’re doing the right tests? If a test is “required” must we do it? In other words, how do we validate our validation? And how do we defend our validation when FDA criticizes it? This presentation will use the case study approach to take a broad approach to validation in an interactive fashion including:
• What are we required to validate and how/when do we do it?
• How do we validate our validation? How do we defend our validation when FDA questions it?
• What are the consequences if our validation is wrong?
• If we change our device, when and how do we revalidate?
• What are the validation challenges for the future?
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Similar to Fda remediation preparation, response and execution (20)
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
Fda remediation preparation, response and execution
1. FDA Remediation: Preparation, Response
and Execution
FDA Remediation
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
2. Instructor Profile:
David Amor is a medical device consultant, having worked with companies such
as Boston Scientific, St. Jude Medical and Hospira in helping develop quality
management systems and product development infrastructures. A graduate of the
Senior Innovation Fellows program at the University of Minnesota Medical Device
Center, David was named a Top 40 Under 40 Medical Device Innovator in 2012 and
founded MEDgineering. David has a strong technical background, having garnered his
BS and MS in Biomedical Engineering from the University of Miami with a focus on
innovating around clinical needs.
He is a published speaker, participating in most major medical device trade shows,
including presentations at MD&M East and MD&M West, the two largest medical
device conferences in the world, where he lectures on topics centering on innovative
compliance practices.
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
3. Description:
FDA actions, 483s or warning letters are scary propositions - unless you know
how to assess and manage them. This course will walk students through reacting to
FDA actions or requests including assessing, planning, responding and follow-up.
Learn through case studies and actual warning letter examples on what to do and
what not to do before, during and after an inspection.
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
4. Why Should you Attend?
Attend this webinar and learn more about FDA Remediation: Preparation,
Response and Execution because all companies will go through FDA remediation at
some point.
Objectives of the Presentation:
Objectives of the presentation are to
discuss about FDA remediation and Quality System.
Who can Benefit?
Medical device professionals.
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
5. Live Session - How it works?
• Username and Password will be sent to you 24 hours prior to the webinar
• Presentation handouts in pdf format will be mailed to you
• Login to the session using the username and password provided to you
• Get answer to your queries through interactive Q&A sessions via chat
• Get certification of attendance.
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
6. Recorded Session - How it works?
• A link will be provided to you upon purchase of the recorded session
• Please click on the link to access the session
• Presentation handouts in pdf format will be mailed to you
• Get certification of attendance.
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
7. Get Connected With Us:
www.onlinecompliancepanel.com
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com